Literature DB >> 11430917

Role of vanilloid VR1 receptor in thermal allodynia and hyperalgesia in diabetic mice.

J Kamei1, K Zushida, K Morita, M Sasaki, S Tanaka.   

Abstract

We examined the role of the vanilloid VR1 receptor in the thermal hyperalgesia and allodynia seen in diabetic mice. Tail-flick latencies at source voltages of 35 and 50 V for a 50-W projection bulb in diabetic mice were significantly shorter than those in non-diabetic mice. Tail-flick latencies at 35 and 50 V in diabetic mice were increased by pretreatment with anti-vanilloid VR1 receptor serum. Intrathecal (i.t.) injection of anti-VR1 serum resulted in a significant increase in the tail-flick latency at 50 V in non-diabetic mice. However, i.t. pretreatment with anti-vanilloid VR1 receptor serum did not affect the tail-flick latency at a heat intensity of 35 V in non-diabetic mice. Thus, it seems likely that thermal allodynia and hyperalgesia in diabetic mice may be due to the sensitization of vanilloid VR1 receptors in primary sensory neurons in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430917     DOI: 10.1016/s0014-2999(01)01059-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy.

Authors:  Olga Ilnytska; Valeriy V Lyzogubov; Martin J Stevens; Viktor R Drel; Nazar Mashtalir; Pal Pacher; Mark A Yorek; Irina G Obrosova
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

Review 2.  TRPpathies.

Authors:  Kirill Kiselyov; Abigail Soyombo; Shmuel Muallem
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

3.  Electroacupuncture counteracts the development of thermal hyperalgesia and the alteration of nerve growth factor and sensory neuromodulators induced by streptozotocin in adult rats.

Authors:  L Manni; F Florenzano; L Aloe
Journal:  Diabetologia       Date:  2011-03-23       Impact factor: 10.122

4.  Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase IIα relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root ganglia.

Authors:  Xiao-Fen He; Yu-Rong Kang; Xue-Yu Fei; Lu-Hang Chen; Xiang Li; Yi-Qi Ma; Qun-Qi Hu; Si-Ying Qu; Han-Zhi Wang; Xiao-Mei Shao; Bo-Yi Liu; Jun-Ying Du; Jian-Qiao Fang; Yong-Liang Jiang
Journal:  Purinergic Signal       Date:  2022-01-01       Impact factor: 3.765

Review 5.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

Review 6.  TRP channels: potential drug target for neuropathic pain.

Authors:  Lovish Marwaha; Yashika Bansal; Raghunath Singh; Priyanka Saroj; Ranjana Bhandari; Anurag Kuhad
Journal:  Inflammopharmacology       Date:  2016-10-18       Impact factor: 4.473

7.  Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes.

Authors:  Xiang Xu; Hui Chen; Bing-Yu Ling; Lan Xu; Hong Cao; Yu-Qiu Zhang
Journal:  Neurosci Bull       Date:  2013-11-05       Impact factor: 5.203

8.  Diabetes-induced chemogenic hypoalgesia is paralleled by attenuated stimulus-induced fos expression in the spinal cord of diabetic mice.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  J Pain       Date:  2007-05-29       Impact factor: 5.820

9.  Role of Transient Receptor Potential Channels Trpv1 and Trpm8 in Diabetic Peripheral Neuropathy.

Authors:  Mallikarjuna R Pabbidi; Louis S Premkumar
Journal:  J Diabetes Treat       Date:  2017-10-17

10.  New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.

Authors:  Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Isabel Devesa; José Manuel González-Ros; Antonio Ferrer-Montiel
Journal:  Pharmaceuticals (Basel)       Date:  2011-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.